AI-generated summary
The authors randomized 32 adults with sub-acute compressive cervical myelopathy to receive photobiomodulation therapy with Class IV laser alongside spinal stimulation, activity-based therapy and physiotherapy, or the same care without the laser, over three weeks. They report significant between-group differences in H-amplitude at day 15 and in JOACMEQ quality-of-life scores at day 7, with within-group improvements in several measures. The trial was not blinded.
- Participants
- 32
- Who or what was studied
- Adults aged 20 to 65 years with sub-acute compressive cervical myelopathy
- Limits stated in the abstract
- The trial was parallel-group and non-blinded with a small sample of 32 participants, and the abstract does not report wavelength or dosing parameters for the laser.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Randomized controlled trial, Photobiomodulation, Control group, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.